Literature DB >> 17542447

Integrating viral hepatitis prevention services into an urban STD clinic: Denver, Colorado.

Julie Subiadur1, Jennie L Harris, Cornelis A Rietmeijer.   

Abstract

The Centers for Disease Control and Prevention recommends integrating viral hepatitis prevention services with services for adults evaluated for sexually transmitted diseases (STDs). The Denver Public Health STD clinic began hepatitis B vaccination in 1999, hepatitis C virus (HCV) antibody (anti-HCV) testing in 2000, and hepatitis A vaccination in 2002. Rapid human immunodeficiency virus (HIV) testing began in late 2004. Hepatitis B vaccinations peaked in 2003 (31/100 client visits) when a full-time nurse was hired to vaccinate and eligibility was expanded. The proportion of clients documented to have received their anti-HCV test results declined from an average of 71% in 2000-2003 to 22% in 2004-2005, coinciding with the introduction of rapid HIV testing. Viral hepatitis prevention services can be incorporated into a busy STD clinic if staff and resources are available. Rapid HIV testing may be associated with lower receipt of anti-HCV test results.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17542447      PMCID: PMC1831809          DOI: 10.1177/00333549071220S203

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  2 in total

1.  Hepatitis B vaccination among high-risk adolescents and adults--San Diego, California, 1998-2001.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2002-07-19       Impact factor: 17.586

2.  Sexually transmitted diseases treatment guidelines 2002. Centers for Disease Control and Prevention.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2002-05-10
  2 in total
  13 in total

1.  Advancing integration of HIV, STD, and viral hepatitis services: state perspectives.

Authors:  Peter Whiticar; Thomas Liberti
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

2.  Integrating viral hepatitis prevention into public health programs serving people at high risk for infection: good public health.

Authors:  Joanna Buffington; T Stephen Jones
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

3.  Managing chronic hepatitis C in primary-care settings: more than antiviral therapy.

Authors:  Barry Zevin
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

4.  CDC and progress toward integration of HIV, STD, and viral hepatitis prevention.

Authors:  John W Ward; Kevin A Fenton
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

5.  Economic benefits of hepatitis B vaccination at sexually transmitted disease clinics in the U.S.

Authors:  M'Kiaira K Miriti; Kaafee Billah; Cindy Weinbaum; Julie Subiadur; Richard Zimmerman; Paula Murray; Robert Gunn; Joanna Buffington
Journal:  Public Health Rep       Date:  2008 Jul-Aug       Impact factor: 2.792

6.  Public health clinic-based hepatitis C testing and linkage to care in Baltimore.

Authors:  O Falade-Nwulia; S H Mehta; J Lasola; C Latkin; A Niculescu; C O'Connor; P Chaulk; K Ghanem; K R Page; M S Sulkowski; D L Thomas
Journal:  J Viral Hepat       Date:  2016-02-03       Impact factor: 3.728

7.  Viral hepatitis vaccination in an opioid treatment program: Hartford, Connecticut, 2002-2005.

Authors:  Paul McLaughlin
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

8.  The costs and impacts of testing for hepatitis C virus antibody in public STD clinics.

Authors:  Amanda A Honeycutt; Jennie L Harris; Olga Khavjou; Joanna Buffington; T Stephen Jones; David B Rein
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

9.  Project ECHO: linking university specialists with rural and prison-based clinicians to improve care for people with chronic hepatitis C in New Mexico.

Authors:  Sanjeev Arora; Karla Thornton; Steven M Jenkusky; Brooke Parish; Joseph V Scaletti
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

10.  Reasons for Nonattendance across the Hepatitis C Disease Course.

Authors:  Gail Butt; Liza McGuinness; Terri Buller-Taylor; Sandi Mitchell
Journal:  ISRN Nurs       Date:  2013-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.